Skip to main content
Clinical Trials/IRCT2017070420258N51
IRCT2017070420258N51
Recruiting
Phase 2

Evaluation of intravenous pamidronate & oral alendronate on bone marrow density in ?patients with major and intermedia thalassemia

Vice chancellor for research, Arak University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Arak University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients with major and inter media thalassemia ,age more than 10 years referred to Amir kabir hospital
  • Exclusion criteria: Gastrointestinal intolerance for oral medication; having an allergic drug; heart failure; liver failure; hypoparathyroidism

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials